HBM Partners
Andreas Wicki is an experienced executive with a strong background in the pharmaceutical and diagnostics industries. Currently serving as CEO of HBM Partners AG since May 2001, Andreas previously held the position of Senior Vice President at MDS Pharma Services from 1990 to 2001 and was the CEO of Vivagen Diagnostics from 1987 to 1989. Andreas holds a Ph.D. in Chemistry from the University of Bern, which was completed between 1980 and 1986.
HBM Partners
HBM Partners was founded in 2001 with the goal to invest in private and public emerging biopharma and other healthcare-related companies. HBM Partners has a team of experienced professionals to source, analyse and engage in investments in biopharma, medical devices and diagnostics industries. HBM Partners has a track-record of over 100 investments that resulted so far in significant value creation by more than 60 trade sales and IPOs since inception. HBM Partners is regulated by FINMA and advises SIX listed HBM Healthcare Investments and further specialised public and private equity investment products.